期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 131, 期 11, 页码 3864-+出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja900601c
关键词
-
资金
- NIH [GM-076320]
- Packard Foundation
- Bristol Myers Squibb
- Eli Lilly
- Roche
A new N-sulfonyloxaziridine reagent for the conversion of N-terminal peptide amines to the corresponding hydroxylamines without overoxidation or erosion of stereochemistry is described. The products are N-terminal hydroxylamines, which are substrates for chemoselective amide-bond forming reactions with alpha-ketoacids. The success of this reagent arises from covalent precomplexation with the substrate via imine bond formation followed by an intramolecular oxygen-atom transfer to the amine. An unexpected stereochemical mismatch between the racemic reagent and the chiral peptide substrates was addressed by the preparation of an enantipure version of this reagent and provides further support for the proposed mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据